Counseling patients with newly diagnosed prostate cancer

被引:0
|
作者
Thompson, IM [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Div Urol, San Antonio, TX 78284 USA
来源
ONCOLOGY-NEW YORK | 2000年 / 14卷 / 01期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Almost 200, 000 men are diagnosed with localized prostate cancer each year. With the burgeoning number of treatment options for this disease, the number of patients seeking second opinions from an increasing variety of medical specialties will continue to increase. In 1999 (and for the foreseeable future), there is no single best treatment for any given patient-only options, Each treatment choice has a variety of advantages, as well as a unique spectrum of complications and side effects, most of which are poorly quantified and difficult to compare among treatments. Much more objective data are available regarding the efficacy and necessity of staging tests for further evaluation of patients after diagnosis. Current information about both staging and treatment alternatives, discussed in this article, should be part of the knowledge base of all physicians treating patients with prostate cancer.
引用
收藏
页码:119 / +
页数:9
相关论文
共 50 条
  • [1] Short-term psychosocial counseling for patients with newly-diagnosed prostate cancer
    Sadetsky, N
    Kneier, A
    Latini, DM
    Knight, S
    Loi, J
    Carroll, PR
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 252 - 252
  • [2] Bone Scanning in Patients with Newly Diagnosed Prostate Cancer
    Jaukovic, L.
    Ajdinovic, B.
    Dopudja, M.
    Dugonjic, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S364 - S364
  • [3] Prostate cancer survivors give advice to newly diagnosed prostate cancer patients
    Branch, L
    Erb, D
    Brown, D
    [J]. GERONTOLOGIST, 2002, 42 : 415 - 416
  • [4] Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer
    Kurian, Allison W.
    Griffith, Kent A.
    Hamilton, Ann S.
    Ward, Kevin C.
    Morrow, Monica
    Katz, Steven J.
    Jagsi, Reshma
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (05): : 531 - 534
  • [5] Current health utility of newly diagnosed prostate cancer patients
    Miles, BJ
    Fearn, PA
    Hu, JC
    Cowen, ME
    Giesler, RB
    Kattan, MW
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 258 - 258
  • [6] Distribution of Prostate Cancer Treatment Options in Newly Diagnosed Patients
    Ham, Yeji
    Weerasinghe, Arosha
    Nzenza, Tatenda
    Bolton, Damien
    Lawrentschuk, Nathan
    Sengupta, Shomik
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 35 - 35
  • [7] Distribution of prostate cancer treatment options in newly diagnosed patients
    Ham, Yeji
    Nzenza, Tatenda
    Weerasinghe, Arosha
    Bolton, Damien
    Lawrentschuk, Nathan
    Sengupta, Shomik
    [J]. BJU INTERNATIONAL, 2018, 122 : 5 - 6
  • [8] Plasma estrogens in newly diagnosed patients for prostate cancer.
    Giton, Frank
    De La Taille, Alexandre
    Allory, Yves
    Vacherot, Francis
    Cussenot, Olivier
    Abbou, Clement-Claude
    Raynaud, Jean P.
    Fiet, Jean
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 536 - 536
  • [9] Assessment of indirect costs of newly diagnosed prostate cancer patients
    Jayavedappa, Ravishankar
    Chhatre, Sumedha
    Whittington, Richard
    Wein, Alan J.
    Malkowicz, S. Bruce
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 97 - 97
  • [10] Local Radiotherapy for Patients with newly diagnosed, metastatic Prostate Cancer
    Guckenberger, Matthias
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (04) : 362 - 364